Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q3VZ
|
|||
Drug Name |
PMID28766366-Compound-Scheme27LeucettineL41
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
GAMBRO LUNDIA AB [SEJOENSSON LENNART [SENILSSON EDDIE [SESTERNBY JAN [SE]
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H13N3O3
|
|||
Canonical SMILES |
C1OC2=C(O1)C=C(C=C2)C=C3C(=O)NC(=N3)NC4=CC=CC=C4
|
|||
InChI |
1S/C17H13N3O3/c21-16-13(8-11-6-7-14-15(9-11)23-10-22-14)19-17(20-16)18-12-4-2-1-3-5-12/h1-9H,10H2,(H2,18,19,20,21)/b13-8-
|
|||
InChIKey |
PGPHHJBZEGSUNE-JYRVWZFOSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target Info | Inhibitor | [1] |
Target's Patent Info | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.